US Patent Issued to ELI LILLY and Co., UNIVERSITE D'AIX-MARSEILLE, INSERM (Institut National De La Sante Et De La Recherche Medicale), INSTITUT JEAN PAOLI & IRENE CALMETTES, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS, MABLINK BIOSCIENCE, UNIVERSITE CLAUDE BERNARD LYON on Sept. 23 for "Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload" (French, Belgian Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,419,964, issued on Sept. 23, was assigned to ELI LILLY AND COMPANY (Indianapolis), UNIVERSITE D'AIX-MARSEILLE (Marseilles, France), INSERM (Institut National De La Sante Et De La Recherche Medicale) (Paris), INSTITUT JEAN PAOLI & IRENE CALMETTES (Marseilles, France), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (Paris), MABLINK BIOSCIENCE (Lyons, France) and UNIVERSITE CLAUDE BERNARD LYON (Villeurbanne, France).

"Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payload" was invented by Jacobus Petrus Maria Elands (Forest, Belgium), Joanna Fares (Aix-en-Provence, France), Guy Fournet (Lyons, France), Benoit Joseph (Villeurbanne, France), Florence Lhospi...